Literature DB >> 28247923

Regulatory T-cell cytokines in patients with nonsegmental vitiligo.

Mehtap Kidir1, Ayse A Karabulut1, Mustafa E Ercin2, Pınar Atasoy2.   

Abstract

In the etiopathogenesis of vitiligo, the role of suppressor cytokines, such as transforming growth factor-β (TGF-β) and interleukin-10 (IL-10), associated with regulatory T-cells (Treg) is not completely known. In this study, the role of Treg-cell functions in the skin of patients with nonsegmental vitiligo was investigated. Lesional and nonlesional skin samples from 30 adult volunteers ranging in age from 18 to 36 years with nonsegmental vitiligo were compared with normal skin area excision specimens of 30 benign melanocytic nevus cases as controls. All samples were evaluated staining for forkhead box P3 (Foxp3), TGF-β, and IL-10 using the standardized streptavidin-biotin immunoperoxidase immunohistochemistry method. Foxp3 expression was lower in lesional vitiligo skin specimens compared to controls; it was also lower in lesional vitiligo specimens than nonlesional vitiligo specimens. IL-10 levels were lower in lesional vitiligo specimens compared to the controls, whereas IL-10 expression was significantly lower in lesional specimens compared with nonlesional specimens. TGF-β expression was higher in both lesional and nonlesional skin specimens of patients with vitiligo compared to controls. TGF-β expression was lower in lesional skin specimens than nonlesional skin specimens. In addition, there was no significant correlation between Foxp3 expression with TGF-β and IL-10 expressions in lesional skin specimens in the vitiligo group. In this study, results supporting the contribution of Treg cells and IL-10 deficiency to the autoimmune process were obtained. Therefore, future studies are necessary to demonstrate the definitive role of Treg-cell functions in the etiopathogenesis of vitiligo.
© 2017 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28247923     DOI: 10.1111/ijd.13564

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Repigmentation of Tenacious Vitiligo on Apremilast.

Authors:  Sara B Huff; Lorie D Gottwald
Journal:  Case Rep Dermatol Med       Date:  2017-11-06

2.  Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo.

Authors:  Hoda Y Abdallah; Noura R Abdelhamid; Eman A Mohammed; Nehal Y AbdElWahab; Noha Z Tawfik; Amal H A Gomaa; Eman A Toraih; Alia Ellawindy
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

Review 3.  Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.

Authors:  Prashant S Giri; Jahanvi Mistry; Mitesh Dwivedi
Journal:  J Immunol Res       Date:  2022-09-16       Impact factor: 4.493

Review 4.  Mechanisms of melanocyte death in vitiligo.

Authors:  Jianru Chen; Shuli Li; Chunying Li
Journal:  Med Res Rev       Date:  2020-11-17       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.